Seeing Is Believing
ADVM is currently covered by 5 analysts with an average price target of $6. This is a potential upside of $-0.76 (-11.24%) from yesterday's end of day stock price of $6.76.
Adverum Biotechnologies's activity chart (see below) currently has 47 price targets and 52 ratings on display. The stock rating distribution of ADVM is 15.38% HOLD and 84.62% BUY.
Analysts average stock forecasts to be materialized ratio is 53.23% with an average time for these price targets to be met of 135.83 days.
Highest price target for ADVM is $40, Lowest price target is $12, average price target is $6.
Most recent stock forecast was given by LUCA ISSI from RBC on 13-Aug-2024. First documented stock forecast 25-Aug-2014.
Currently out of the existing stock ratings of ADVM, 2 are a HOLD (15.38%), 11 are a BUY (84.62%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
12
$5.06 (72.91%)
30
24 days ago
1/5 (20%)
$5.24 (77.51%)
35
Buy
30
$23.06 (332.28%)
30
24 days ago
0/3 (0%)
$23.24 (343.79%)
Buy
40
$33.06 (476.37%)
4
1 months 19 days ago
1/4 (25%)
$30.52 (321.94%)
543
Buy
22
$15.06 (217.00%)
40
4 months 8 days ago
2/5 (40%)
$12.47 (130.85%)
52
Buy
6
$4.05 (207.69%)
4
1 years 2 days ago
4/7 (57.14%)
$4.22 (237.08%)
196
What is ADVM (Adverum Biotechnologies) average time for price targets to be met?
Which analyst has the current highest performing score on ADVM (Adverum Biotechnologies) with a proven track record?
Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?
Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?
Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?